Researchers from IOCB Prague are furthering the understanding of how medicines work and what it takes to develop their most effective variants.
Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – July 15, 2024) – Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), (“Braxia Scientific”, or the “Company”), today announced